文献引用
-
1) 4-OI improves mitochondria-associated endoplasmic reticulum membrane dysfunction by regulating MFN2 through Nrf2 transcription and alleviates airway inflammation in asthma exposed to PM2.5 early in life.
-
2) San-Huang-Chai-Zhu formula alleviates intrahepatic cholestasis through PPARα-mediated bile acid homeostasis and MKK4/JNK pathway.
-
3) Microbial metabolite trimethylamine N-oxide exacerbated microglial-mediated neuroinflammation in hemorrhagic stroke.
-
4) Weimishu prescription alleviates liver-stomach disharmony and chronic gastritis by reducing inflammation and regulating gastric stem cell differentiation.
-
5) USP16 promotes M2 polarization of macrophages in colorectal cancer by activating the Notch pathway via inducing the deubiquitination of E2F1.
-
6) Ginsenoside Rg2 upregulates expression of Lilrb4 and inhibits the NF-κB signaling pathway to alleviate hemorrhagic shock/reperfusion-induced intestinal injury.
-
7) BML-111 mitigates phosgene-induced acute lung injury in rats by activating ACE2.
-
8) Exploring the mechanism of the Lianshi Jianpi formula in treating impaired glucose tolerance: a network pharmacology, molecular docking, and experimental validation study.
-
9) Salidroside attenuates calcium oxalate-induced renal injury via suppression of PANoptosis.
-
10) Myristicin inhibits the progression of non-small cell lung cancer by deactivating the Wnt/β-catenin pathway.
-
11) A Topical Chinese Herbal Alleviates Psoriasis by Regulating Keratinocytes Pyroptosis Through Inhibition of NLRP3 Inflammasome Activation.
-
12) Resveratrol Suppresses Sepsis-Induced Micro-vascular Hypo-reactivity Through Rac1-MLCK Pathway.
-
13) Lingguizhugan Decoction Alleviates Lung Inflammatory in Obstructive Sleep Apnea by Modulating ROS and HIF-1α Signaling Pathway Based on UHPLC-MS, Network Pharmacology, Transcriptomics, and Experimental Verification.
-
14) MiR-423-5p inhibition alleviates podocyte apoptosis in membranous nephropathy by targeting WT1/β-catenin axis.
-
15) A System Pharmacology Approach: Deciphering Atheroprotective Mechanisms of Yi-Mai Compound Through Integrative Analysis of UPLC-ESI-MS Profiling, Network Targeting, and Molecular Docking.